The Icelandic Endocrine Society Endorses RetinaRisk

Retina Risk has received an official recognition and endorsement from The Icelandic Endocrine Society. The endorsement reflects the extensive research that has gone into designing the Retina Risk solution and the value Endocrinologists see in the application for their patients. The app contributes greatly to empowering people living with diabetes around the world and we are very honored to receive the support.

Similar Posts

  • Lions Club Cooperation with RetinaRisk Accelerates

    The spiraling prevalence of diabetes worldwide means that millions more people are developing complications such as diabetic retinopathy. Health practitioners and people with diabetes need to be aware of this exploding problem and the simple steps that can be taken to reduce the risk of visual impairment. Blindness from diabetic retinopathy is largely avoidable but…

  • The 2019 World Diabetes Atlas

    The International Diabetes Federation published the 9th edition of the World Diabetes Atlas on  November 14, in celebration of World Diabetes Day. The World Diabetes Atlas provides a comprehensive overview of statistics regarding diabetes, including prevalence of diabetes today but also estimates into the future. The Atlas outlines the individual, social and economic impact of…

  • | | |

    We are live – Meet the iClinic!

    Retinopathy risk and diabetic eye screening management revolutionized We at RetinaRisk have launched the iClinic, our browser-based decision support tool for improved diabetic eye health. The RetinaRisk iClinic enables healthcare professionals around the world to revolutionize their approach to diabetic eye care by swiftly identifying patients who are most at risk of developing sight-threatening diabetic…

  • |

    How To Prevent Diabetic Retinopathy?

    Diabetic retinopathy is one of the most common complications of diabetes. It’s an eye condition that affects blood vessels in the retina, the innermost layer lining the back of the inside the eye. It occurs due to damage to the small capillaries that supply blood to the light-sensitive retina at the back of the eye….

  • |

    The Importance of Individual Diabetic Retinopathy Screenings

    Personalizing screening for sight-threatening diabetic retinopathy was on the agenda at this year‘s annual meeting of the European Association for the Study of Diabetes (EASD), which was held in Barcelona, Spain in September 2019. One of our founders, Dr. Arna Guðmundsdóttir, Endocrinologist at the National Hospital in Iceland, attended the meeting and shared with us…

  • RetinaRisk wins NLS Invest Rising Star Award

    Following a tight battle between 80 candidates, the prestigious NLS Invest has given an award to RetinaRisk, alongside ApoGlyx from Sweden and Respinor from Norway as a “Rising Star” in the Digital/E-Health chapter for startups and selected to pitch to investors at the NLS Days. As per Nordic Life Sciences News, “The three winners will…